Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer.
The incidence of cSCC is increasing globally and the prognosis of metastatic disease is …

Background The incidence of epidermal keratinocyte‐derived cutaneous squamous cell
carcinoma (cSCC) is increasing worldwide. Objectives To study the role of the complement …

Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer,
with increasing incidence worldwide. Previous studies have shown the role of the …

Cutaneous squamous cell carcinoma (cSCC) is one of the most common metastatic skin
cancers with increasing incidence. We examined the roles of complement component C3 …

Background Complement C3 has been shown to be highly expressed in cutaneous
squamous cell carcinoma (cSCC) tumour tissues and is correlated with tumour cell growth …

Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of neoplastic disorders
characterized by clonally derived and skin-homing malignant T cells that express high level …

Tumor immunotherapy has shown great progress for the treatment of cancer; however, both
endogenous and exogenous T cells are inhibited by the immunosuppressive tumor …

Nonmelanoma skin cancer such as cutaneous squamous cell carcinoma (cSCC) is the most
common form of cancer and can occur as a consequence of DNA damage to the epithelium …

Purpose: Our goal is to test whether CS1 could be targeted by chimeric antigen receptor
(CAR) T cells to treat multiple myeloma (MM). Experimental Design: We generated a …

Introduction The restricted expression of CD19 in the B-cell lineage makes it an attractive
target for the therapeutic treatment of B-cell malignancies. Many monoclonal antibodies and …